G logo

G

Genpact Limited

$47.78
+$0.42(+0.89%)
80
Overall
100
Value
72
Tech
68
Quality
Market Cap
$7.97B
Volume
1.66M
52W Range
$37.49 - $56.76
Target Price
$50.20

Latest News for G

Jefferies Reaffirms Their Buy Rating on McDonald’s (MCD)
TipRanks Auto-Generated Intelligence Newsdesk3 hours agoDec 14, 2025

In a report released on December 11, Scott Marks CFA from Jefferies reiterated a Buy rating on McDonald’s. The company’s shares closed last Friday ......

Galderma Group AG (GALD) Receives a Buy from UBS
TipRanks Auto-Generated Intelligence Newsdesk3 hours agoDec 14, 2025

In a report released on December 11, Matthew Weston from UBS maintained a Buy rating on Galderma Group AG. The company’s shares closed last Friday ......

Walmart (WMT) Gets a Buy from Morgan Stanley
TipRanks Auto-Generated Intelligence Newsdesk3 hours agoDec 14, 2025

Morgan Stanley analyst Simeon Gutman initiated coverage with a Buy rating on Walmart on December 11 and set a price target of $125.00. The company’......

Jefferies Reaffirms Their Buy Rating on Engie SA (0LD0)
TipRanks Auto-Generated Intelligence Newsdesk4 hours agoDec 14, 2025

Jefferies analyst Zach Ho reiterated a Buy rating on Engie SA on December 11 and set a price target of €25.00. The company’s shares closed last Fri......

Anglo American (AAUKF) Gets a Hold from Panmure Liberum
TipRanks Auto-Generated Intelligence Newsdesk4 hours agoDec 14, 2025

Panmure Liberum analyst reiterated a Hold rating on Anglo American today and set a price target of p2,500.00. In addition to Panmure Liberum, Anglo......

Mizuho Securities Sticks to Their Buy Rating for Synopsys (SNPS)
TipRanks Auto-Generated Intelligence Newsdesk4 hours agoDec 14, 2025

Mizuho Securities analyst Siti Panigrahi reiterated a Buy rating on Synopsys on December 11. The company’s shares closed last Friday at $477.26. Ac......

Jefferies Reaffirms Their Hold Rating on Endesa SA (0N9G)
TipRanks Auto-Generated Intelligence Newsdesk4 hours agoDec 14, 2025

In a report released on December 11, Ahmed Farman from Jefferies reiterated a Hold rating on Endesa SA, with a price target of €27.00. The company’......

Regeneron Initiates Promising Phase 2 Study on Diabetic Kidney Disease
TipRanks Clinical-Trials-Auto-Generated Newsdesk4 hours agoDec 14, 2025

Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals is initiating a Phase 2 study titl......

Amgen’s New Phase 3 Trial: A Potential Game-Changer for Obstructive Sleep Apnea Treatment
TipRanks Clinical-Trials-Auto-Generated Newsdesk4 hours agoDec 14, 2025

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. has initiated a Phase 3 clinical trial titled A Phase 3 Randomize......

Argenx’s Efgartigimod Study: A New Horizon in CIDP Treatment
TipRanks Clinical-Trials-Auto-Generated Newsdesk4 hours agoDec 14, 2025

Argenx ($ARGX) announced an update on their ongoing clinical study. Argenx is currently recruiting participants for a study titled ‘Real-World Efga......

News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 9033 articles.

ABCD
1SymbolPriceChangeVol
2G$47.78+0.9%1.66M
3
4
5
6

Get Genpact Limited Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.